02511.HK
HighTide Therapeutics Inc
HKSE · Healthcare · Biotechnology · CN
HKD 3.10
−0.32%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-162.2%
Return on equity
-71.6%
Return on assets
-54.7%
Return on invested capital
0.00x
Asset turnover
-HKD 181.1M
Cash from operations
HKD 0.75
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026